Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 3/20 | 0.33 |
| ▸ | NOS1 | P29475 | 3/20 | 0.33 |
| ▸ | NOS2 | P35228 | 3/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34468141 | 1.00 | CYP2C9 (0.44) | CYP2C9TSHRCYP2C19TDP1NOS3 | |
| SCHEMBL1269845 | 1.00 | CYP2C9 (0.44) | CYP2C9TSHRCYP2C19TDP1NOS3 | |
| SCHEMBL6585508 | 0.95 | — | — | |
| SCHEMBL7075565 | 0.95 | TDP1 (0.41) | CYP2C9TSHRCYP2C19TDP1NOS3 | |
| SCHEMBL2368 | 0.95 | — | — | |
| SCHEMBL3001521 | 0.91 | ACHE (0.42) | CYP2C9TSHRCYP2C19TDP1ACHE | |
| SCHEMBL1269311 | 0.91 | EPHX1 (0.40) | CYP2C9TSHRCYP2C19TDP1NOS3 | |
| Hydrochloric Acid SCHEMBL1937438 | 0.90 | — | — | |
| Ammonia Solution, Strong SCHEMBL3799540 | 0.90 | — | — | |
| Water SCHEMBL17309998 | 0.90 | CYP2C9 (0.44) | CYP2C9TSHRCYP2C19TDP1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140148623-A1 | FUEL COMPOSITIONS COMPRISING ISOPRENE DERIVATIVES | DANISCO US INC. (US) | 2014-05-29 | — | — | US | disclosed |
| US-8450549-B2 | Fuel compositions comprising isoprene derivatives | DANISCO US INC. (US) | 2013-05-28 | — | — | US | disclosed |
| EP-2448891-A1 | FUEL COMPOSITIONS COMPRISING ISOPRENE DERIVATIVES | Danisco US Inc. (US) | 2012-05-09 | — | — | EP | disclosed |
| US-20110046422-A1 | FUEL COMPOSITIONS COMPRISING ISOPRENE DERIVATIVES | DANISCO US INC. | 2011-02-24 | — | — | US | disclosed |
| WO-2010148256-A1 | FUEL COMPOSITIONS COMPRISING ISOPRENE DERIVATIVES | DANISCO US INC. (US) | 2010-12-23 | — | — | WO | disclosed |
| EP-1049370-A4 | SESQUITERPENE SYNTHASES FROM GRAND FIR $i(ABIES GRANDIS), AND METHODS OF USE | UNIV WASHINGTON (US) | 2004-10-06 | — | — | EP | disclosed |
| US-6451576-B1 | ISOLATED NUCLEIC ACIDS THAT ENCODE GYMNOSPERM SESQUITERPENE SYNTHASES | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION | 2002-09-17 | — | — | US | disclosed |
| US-6265639-B1 | INTRODUCING INTO THE HOST CELL AN EXPRESSION VECTOR OF THE PRESENT INVENTION UNDER CONDITIONS ENABLING EXPRESSION OF THE SESQUITERPENE SYNTHASE PROTEIN IN THE HOST CELL | WASHINGTON STATE UNIVERSITY FOUNDATION | 2001-07-24 | — | — | US | disclosed |
| EP-1049370-A1 | SESQUITERPENE SYNTHASES FROM GRAND FIR $i(ABIES GRANDIS), AND METHODS OF USE | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2000-11-08 | — | — | EP | disclosed |
| WO-1999037139-A1 | SESQUITERPENE SYNTHASES FROM GRAND FIR ABIES GRANDIS, AND METHODS OF USE | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1999-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046422-A1 | FUEL COMPOSITIONS COMPRISING ISOPRENE DERIVATIVES | GGPS1, FNTA, COASY | CYP2C9 512/4885TSHR 4527/4885CYP2C19 678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.